Amgen Inc (AMGN) stock
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3023% above fair value
$438.82−5.07 (-1.14%)
Close on Nov 19, 2026Market cap $237.24BP/E 25.4Yield 2.20%
Amgen shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Amgen's shares outstanding was 546M at Sep 30, 2026. For fiscal 2025 it was 542M, up 0.2% from the year before. Over ten years it grew -3.4% a year on average. The highest annual figure on record is 1.12B in fiscal 2007.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 542M | +0.2% |
| FY2024 | Dec 31, 2024 | 541M | +0.6% |
| FY2023 | Dec 31, 2023 | 538M | -0.6% |
| FY2022 | Dec 31, 2022 | 541M | -5.6% |
| FY2021 | Dec 31, 2021 | 573M | -2.9% |
| FY2020 | Dec 31, 2020 | 590M | -3.1% |
| FY2019 | Dec 31, 2019 | 609M | -8.4% |
| FY2018 | Dec 31, 2018 | 665M | -9.5% |
| FY2017 | Dec 31, 2017 | 735M | -2.5% |
| FY2016 | Dec 31, 2016 | 754M | -1.6% |
| FY2015 | Dec 31, 2015 | 766M | -0.5% |
| FY2014 | Dec 31, 2014 | 770M | +0.7% |
| FY2013 | Dec 31, 2013 | 765M | -2.8% |
| FY2012 | Dec 31, 2012 | 787M | -13.7% |
| FY2011 | Dec 31, 2011 | 912M | -5.5% |
| FY2010 | Dec 31, 2010 | 965M | -5.5% |
| FY2009 | Dec 31, 2009 | 1.02B | -5.0% |
| FY2008 | Dec 31, 2008 | 1.07B | -4.3% |
| FY2007 | Dec 31, 2007 | 1.12B | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 546M | +0.7% |
| Q2 FY2026 | Jun 30, 2026 | 544M | +0.6% |
| Q1 FY2026 | Mar 31, 2026 | 544M | +0.6% |
| Q4 FY2025 | Dec 31, 2025 | 542M | +0.2% |
| Q3 FY2025 | Sep 30, 2025 | 542M | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | 541M | 0.0% |
| Q1 FY2025 | Mar 31, 2025 | 541M | +0.9% |
| Q4 FY2024 | Dec 31, 2024 | 541M | +0.6% |
| Q3 FY2024 | Sep 30, 2024 | 542M | +0.7% |
| Q2 FY2024 | Jun 30, 2024 | 541M | +0.7% |
| Q1 FY2024 | Mar 31, 2024 | 536M | -0.4% |
| Q4 FY2023 | Dec 31, 2023 | 538M | 0.0% |
| Q3 FY2023 | Sep 30, 2023 | 538M | 0.0% |
| Q2 FY2023 | Jun 30, 2023 | 537M | 0.0% |
| Q1 FY2023 | Mar 31, 2023 | 538M | -2.4% |
| Q4 FY2022 | Dec 31, 2022 | 538M | -4.6% |
| Q3 FY2022 | Sep 30, 2022 | 538M | -7.4% |
| Q2 FY2022 | Jun 30, 2022 | 537M | -8.0% |
| Q1 FY2022 | Mar 31, 2022 | 551M | -6.5% |
| Q4 FY2021 | Dec 31, 2021 | 564M | -4.7% |
| Q1 FY2021 | Mar 31, 2021 | 581M | -2.2% |
| Q4 FY2020 | Dec 31, 2020 | 584M | -4.3% |
| Q3 FY2020 | Sep 30, 2020 | 589M | -5.9% |
| Q2 FY2020 | Jun 30, 2020 | 592M | -7.6% |
| Q1 FY2020 | Mar 31, 2020 | 594M | -8.5% |
| Q2 FY2019 | Jun 30, 2019 | 610M | -7.6% |
| Q1 FY2019 | Mar 31, 2019 | 626M | -12.0% |
| Q4 FY2018 | Dec 31, 2018 | 641M | -11.7% |
| Q3 FY2018 | Sep 30, 2018 | 649M | -11.5% |
| Q2 FY2018 | Jun 30, 2018 | 660M | -10.6% |
| Q1 FY2018 | Mar 31, 2018 | 711M | -4.0% |
| Q4 FY2017 | Dec 31, 2017 | 726M | -2.2% |
| Q3 FY2017 | Sep 30, 2017 | 733M | -2.7% |
| Q2 FY2017 | Jun 30, 2017 | 738M | -2.4% |
| Q1 FY2017 | Mar 31, 2017 | 741M | – |
| Q4 FY2016 | Dec 31, 2016 | 742M | – |
| Q3 FY2016 | Sep 30, 2016 | 753M | – |
| Q2 FY2016 | Jun 30, 2016 | 756M | – |
See a number that looks wrong?